Literature DB >> 31140037

Pitfalls in meta-analysis.

Andriko Palmowski1, Sabrina M Nielsen2,3.   

Abstract

Systematic reviews with meta-analyses are powerful instruments to synthesize research. If done correctly, they may constitute the highest level of evidence by combining several individual studies. As high-quality evidence is scarce in the field of complementary medicine, meta-analyses of randomized trials may shed new light on both efficacy and safety, but they must be properly conducted. In this commentary to a recently published paper we elaborate on methodological pitfalls in meta-analysis that every researcher should avoid to gain true high-quality evidence.

Entities:  

Keywords:  Evidence synthesis; Meta-analysis; Methodology; Systematic review

Mesh:

Year:  2019        PMID: 31140037     DOI: 10.1007/s10787-019-00606-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  4 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

Review 2.  The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials.

Authors:  Abdelrahman Tarek Mohammed; Mohammed Khattab; Ali Mahmoud Ahmed; Tarek Turk; Nora Sakr; Adham M Khalil; Mohamed Abdelhalim; Bisher Sawaf; Kenji Hirayama; Nguyen Tien Huy
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

3.  The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials.

Authors:  Seyed Mohammad Aqaeinezhad Rudbane; Samane Rahmdel; Seyedeh Maryam Abdollahzadeh; Morteza Zare; Azam Bazrafshan; Seyed Mohammad Mazloomi
Journal:  Inflammopharmacology       Date:  2018-01-04       Impact factor: 4.473

4.  Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses.

Authors:  Nikola Panic; Emanuele Leoncini; Giulio de Belvis; Walter Ricciardi; Stefania Boccia
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

  4 in total
  1 in total

1.  Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking.

Authors:  Yi Liu; Xin Cui; Junyu Xi; Yanming Xie
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.